Sign in
4

Changes in Ownership

BIO-TECHNE Corp Filed Acc 0001062993-25-013134

Chief Executive Officer gave up 43,649 shares (to pay taxes)

  • Chief Executive Officer acquired 48,176 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Kelderman Kim Chief Executive Officer 2025-07-22 Option exercise +48,176 $44.33 $2,135,642 90,379 D
Kelderman Kim Chief Executive Officer 2025-07-22 Shares withheld for taxes −43,649 $53.12 $2,318,635 46,730 D
Derivatives
Kelderman Kim Chief Executive Officer 2025-07-22 Option exercise · Stock Option (Right to Buy) −48,176 0 D
Loading xslF345X05/form4.xml…